Obalon Therapeutics, Inc. (OBLN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7800+0.1300 (+4.91%)
At close: 4:00PM EST
| Previous close | 2.6500 |
| Open | 2.6800 |
| Bid | 2.6200 x 1000 |
| Ask | 2.7800 x 1400 |
| Day's range | 2.3000 - 2.9800 |
| 52-week range | 0.6200 - 10.7700 |
| Volume | 2,696,131 |
| Avg. volume | 13,484,991 |
| Market cap | 21.603M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Nov 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.15 |
- PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, OBLN, IACA, and TPGY Shareholders About Its Ongoing Investigations
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
- PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CUB, CRHM, GLUU, OXFD, OBLN; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
- PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of CHNG, CPAH, HMSY, INFO, MGLN, NAV, OBLN, OXFD, and WTRE
Change Healthcare Inc. (NASDAQ: CHNG)
© 2021 Verizon Media. All rights reserved.
